Lupus

Titel Veröffentlichungsdatum Sprache Zitate
Ethnic and geographical differences in systemic lupus erythematosus: an overview2006/11/01English163
Current causes of death in systemic lupus erythematosus in Europe, 2000—2004: relation to disease activity and damage accrual2007/05/01English161
Recombinant human Dnase I (rhDNase) in patients with lupus nephritis1999/01/01English160
Differences by race, sex and age in the clinical and immunologic features of recently diagnosed systemic lupus erythematosus patients in the southeastern United States2002/03/01English159
The nature and outcome of infection in systemic lupus erythematosus2002/04/01English159
Apoptosis in the pathogenesis of systemic lupus erythematosus2008/05/01English158
The interferon-α signature of systemic lupus erythematosus2010/08/01English155
Vasculitis in systemic lupus erythematosus1997/03/01English153
Cigarette smoking and autoimmune disease: what can we learn from epidemiology?2006/11/01English152
High levels of circulating early apoptic peripheral blood mononuclear cells in systemic lupus erythematosus1998/02/01English144
Differences in disease phenotype and severity in SLE across age groups2016/07/11English143
Infections in systemic lupus erythematosus: a prospective and controlled study of 110 patients2006/09/01English141
Longitudinal expression of type I interferon responsive genes in systemic lupus erythematosus2009/09/17English139
Autologous mesenchymal stem cell treatment increased T regulatory cells with no effect on disease activity in two systemic lupus erythematosus patients2009/11/17English138
Detection of coronary artery disease and the role of traditional risk factors in the Hopkins Lupus Cohort2000/03/01English138
Factors associated with poor outcomes in patients with lupus nephritis2005/11/01English136
The blood-brain barrier in systemic lupus erythematosus2003/12/01English135
Review: Lupus nephritis: pathologic features, epidemiology and a guide to therapeutic decisions2010/01/20English133
Effect of hydroxychloroquine treatment on pro-inflammatory cytokines and disease activity in SLE patients: data from LUMINA (LXXV), a multiethnic US cohort2012/02/17English133
Hydroxychloroquine sulfate treatment is associated with later onset of systemic lupus erythematosus2007/06/01English133
Hydroxychloroquine use predicts complete renal remission within 12 months among patients treated with mycophenolate mofetil therapy for membranous lupus nephritis2006/06/01English132
Autologous stem cell transplantation for systemic lupus erythematosus2004/03/01English131
Prognostic determinants in lupus nephritis: a long-term clinicopathologic study1995/04/01English131
International consensus for a definition of disease flare in lupus2010/12/10English130
Review: Vitamin D, immunity and lupus2008/01/01English130
Outcome of patients with anticardiolipin antibodies: a 10 year follow-up of 52 patients1998/01/01English130
Abnormality of bone marrow-derived mesenchymal stem cells in patients with systemic lupus erythematosus2007/02/01English129
Assessing disease activity in SLE patients during pregnancy1999/10/01English127
The Euro-Phospholipid project: epidemiology of the antiphospholipid syndrome in Europe2009/08/11English126
Serious infections in British patients with systemic lupus erythematosus: hospitalisations and mortality2009/06/05English125